CD274 and neoplasm: PD-L1 expression is commonly associated with poor prognosis and can be used to predict the efficacy of anti-PD-1/PD-L1 therapy.102, 103, 104 PD-L1 may promote tumor cell proliferation and progression and participate in the regulation of epithelial–mesenchymal transition.105